Rigel Pharmaceuticals (NASDAQ:RIGL – Get Rating) was downgraded by Jefferies Financial Group from a “buy” rating to a “hold” rating in a research report issued on Wednesday, The Fly reports. A number of other brokerages also recently weighed in on RIGL. StockNews.com started coverage on shares of Rigel Pharmaceuticals in a report on Thursday, March […]
